Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Markman Microsurfaced ADM vs AlloDerm for Gingival Recession
NCT04614350Phase 4Completed
- Sponsor
- McGuire Institute
- Start
- Oct 2020
- Primary completion
- Feb 2022
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial (2 arms), sponsored by McGuire Institute. Primary endpoints: Graft healing assessed by color at Day 14, Graft healing assessed by texture at Day 14 and 3 more. Started Oct 2020; status: completed.
Beyond the preview
Go deeper on NCT04614350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04614350.